Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on BaNIT Mutant. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110714002B discloses a highly efficient nitrilase mutant for synthesizing (S)-3-cyano-5-methylhexanoic acid, offering superior stereoselectivity and solubility for scalable pharmaceutical manufacturing.